Key facts
- This page summarizes Boxer Capital, LLC's Form 4 filing for Tyra Biosciences, Inc. (TYRA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 08 Feb 2024, 17:09.
Boxer Capital, LLC - 06 Feb 2024 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)
- Reporting relationship
- Other*
- Issuer ticker
- TYRA
- Reported as of
- 06 Feb 2024
- Net transaction value
- +$9,999,978
- SEC form
- 4
- Accepted by SEC
- 08 Feb 2024, 17:09:52 UTC
- Prior SEC filing
- 25 Jan 2024
- Next SEC filing
- 14 May 2024
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Aaron I. Davis, Chief Executive Officer, Boxer Capital, LLC
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Boxer Capital, LLC filed Form 4 for Tyra Biosciences, Inc. (TYRA) on 08 Feb 2024.
Change
- Previous filing in this sequence was filed on 25 Jan 2024.
- Current net transaction value: +$9,999,978.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TYRA
transaction
Common Stock
Award
- Transaction value
- $824,990
- Shares
- +63,412
- Change %
- +281%
- Price
- $13.01
- Shares after
- 85,939
- Date
- 06 Feb 2024
- Ownership
- See Footnote
- Footnotes
- F1
TYRA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 6,448,359
- Date
- 06 Feb 2024
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TYRA
transaction
Derivative
Warrant (right to purchase)
Award
- Transaction value
- $9,174,988
- Shares
- +705,280
- Change %
- Price
- $13.01
- Shares after
- 705,280
- Date
- 06 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 705,280
- Exercise price
- $0.001000
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
These securities are owned directly by MVA Investors, LLC ("MVA Investors"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.
Footnote F2
These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"). Boxer Asset Management Inc. ("Boxer Management") is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Management. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.
Footnote F3
These Warrants are exercisable immediately (subject to any applicable beneficial ownership limitation) and do not have an expiration date.
SEC remarks
The reporting persons may be deemed members of a group that beneficially owns more than 10% of the outstanding shares of the outstanding shares of Tyra Biosciences, Inc. common stock ("Common Stock"), par value $0.0001 per share